1. Home
  2. ARVN vs FPI Comparison

ARVN vs FPI Comparison

Compare ARVN & FPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARVN
  • FPI
  • Stock Information
  • Founded
  • ARVN 2015
  • FPI 2013
  • Country
  • ARVN United States
  • FPI United States
  • Employees
  • ARVN N/A
  • FPI N/A
  • Industry
  • ARVN Biotechnology: Pharmaceutical Preparations
  • FPI Real Estate Investment Trusts
  • Sector
  • ARVN Health Care
  • FPI Real Estate
  • Exchange
  • ARVN Nasdaq
  • FPI Nasdaq
  • Market Cap
  • ARVN 456.2M
  • FPI 516.0M
  • IPO Year
  • ARVN 2018
  • FPI 2014
  • Fundamental
  • Price
  • ARVN $7.80
  • FPI $11.27
  • Analyst Decision
  • ARVN Buy
  • FPI
  • Analyst Count
  • ARVN 21
  • FPI 0
  • Target Price
  • ARVN $20.53
  • FPI N/A
  • AVG Volume (30 Days)
  • ARVN 2.2M
  • FPI 486.5K
  • Earning Date
  • ARVN 07-29-2025
  • FPI 07-23-2025
  • Dividend Yield
  • ARVN N/A
  • FPI 2.13%
  • EPS Growth
  • ARVN N/A
  • FPI 104.48
  • EPS
  • ARVN N/A
  • FPI 1.09
  • Revenue
  • ARVN $426,900,000.00
  • FPI $56,535,000.00
  • Revenue This Year
  • ARVN $4.26
  • FPI N/A
  • Revenue Next Year
  • ARVN N/A
  • FPI N/A
  • P/E Ratio
  • ARVN N/A
  • FPI $10.36
  • Revenue Growth
  • ARVN 498.74
  • FPI N/A
  • 52 Week Low
  • ARVN $5.90
  • FPI $9.66
  • 52 Week High
  • ARVN $34.11
  • FPI $12.87
  • Technical
  • Relative Strength Index (RSI)
  • ARVN 58.03
  • FPI 52.31
  • Support Level
  • ARVN $7.09
  • FPI $11.24
  • Resistance Level
  • ARVN $7.85
  • FPI $11.52
  • Average True Range (ATR)
  • ARVN 0.40
  • FPI 0.19
  • MACD
  • ARVN 0.06
  • FPI -0.06
  • Stochastic Oscillator
  • ARVN 71.43
  • FPI 5.00

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.

Share on Social Networks: